rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
2009-11-20
|
pubmed:abstractText |
MARCH-I (membrane-associated RING-CH I) has been suggested as a physiological E3 ubiquitin ligase for both MHC class II (MHC II) and B7-2. In this study, we show that MARCH-I-mediated MHC II ubiquitination is necessary for the maintenance of conventional dendritic cell (cDC) functions in the steady state. MARCH-I-deficient cDCs accumulated MHC II and B7-2 and exhibited low Ag-presenting ability for exogenous Ags and low cytokine-producing ability upon stimulation in vivo. Importantly, MHC II, but not B7-2, was required for impaired cDC function induced by loss of MARCH-I in vivo. Moreover, MHC II knockin mice whose MHC II was not ubiquitinated showed dysfunction of cDC similar to that of MARCH-I knockout mice. These results suggest that the accumulation of MHC II resulting from loss of ubiquitination caused cDC abnormality; therefore, MARCH-I may function as a housekeeper of cDC in the steady state.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD4,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD8,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD86,
http://linkedlifedata.com/resource/pubmed/chemical/Cd86 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Histocompatibility Antigens Class II,
http://linkedlifedata.com/resource/pubmed/chemical/MARCH-I protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Ubiquitin-Protein Ligases
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1550-6606
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
183
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
6893-7
|
pubmed:meshHeading |
pubmed-meshheading:19917682-Animals,
pubmed-meshheading:19917682-Antigen Presentation,
pubmed-meshheading:19917682-Antigens, CD4,
pubmed-meshheading:19917682-Antigens, CD8,
pubmed-meshheading:19917682-Antigens, CD86,
pubmed-meshheading:19917682-Dendritic Cells,
pubmed-meshheading:19917682-Flow Cytometry,
pubmed-meshheading:19917682-Gene Expression,
pubmed-meshheading:19917682-Gene Expression Regulation,
pubmed-meshheading:19917682-Gene Knock-In Techniques,
pubmed-meshheading:19917682-Genes, MHC Class II,
pubmed-meshheading:19917682-Histocompatibility Antigens Class II,
pubmed-meshheading:19917682-Mice,
pubmed-meshheading:19917682-Mice, Inbred C57BL,
pubmed-meshheading:19917682-Mice, Knockout,
pubmed-meshheading:19917682-Ubiquitin-Protein Ligases,
pubmed-meshheading:19917682-Ubiquitination
|
pubmed:year |
2009
|
pubmed:articleTitle |
Cutting edge: requirement of MARCH-I-mediated MHC II ubiquitination for the maintenance of conventional dendritic cells.
|
pubmed:affiliation |
Laboratory for Infectious Immunity, RIKENResearch Center for Allergy and Immunology, Tsurumi-ku, Yokohama, Kanagawa, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|